Compliance With Treatment For Patients With Hyperlipidemia (COLL)

Viatris

Status: Completed

Conditions: Hyperlipidemia

Treatments: Device: Lipid Self Test

Study type: Observational

Funder types: Industry

Identifiers

NCT00828945

A2581178

Details and patient eligibility

About

It is a prospective observational study.

Patients will be high risk patients (for developing cardiovascular events) that are treated with a statin. Patients will be enrolled at a normal clinic visit and provided with a small box containing info about the disease, a LDL self-test and two questionnaires. They will test themselves for LDL at home between normal clinic visits (normally 12 months interval) and note their value. In the end of the study all patients will fill out a questionnaire with questions if the tests and info have raised their awareness of the disease as well if their motivation to be compliant has increased.

We want to look at the possibility to put more responsibility for treatment and for reaching treatment goals on the patients since there's a big problem with compliance in this group of patients.

Full description

Consecutive patient sampling

Enrollment: 259 patients

Sex: All

Ages: 18 to 100 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Aged 18 years or older and able to understand and sign the informed consent form.

  • Patients diagnosed with hyperlipidemia and a very high risk developing cardiovascular disease prescribed statin treatment according to clinical praxis and the recommendations set forth in the MPA national guideline for treatment of hyperlipidemia.

Exclusion criteria

• Patients contraindicated for statin treatment according to market authorization for these drugs should be excluded from the study.
• Patients participating in other clinical trials or non-interventional studies.

Trial design

259 participants in 1 patient group

Hyperlipidemic Patients

Treatment:

Device: Lipid Self Test